Jimenez Rocio, Ikonomopoulou Maria P, Lopez J Alejandro, Miles John J
Griffith University, School of Natural Sciences, Brisbane, Queensland, Australia; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Medicine, The University of Queensland, Brisbane, Australia; Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC, Madrid, Spain.
Toxicon. 2018 Jan;141:18-24. doi: 10.1016/j.toxicon.2017.11.006. Epub 2017 Nov 21.
This review catalogues recent advances in knowledge on venoms as standalone therapeutic agents or as blueprints for drug design, with an emphasis on venom-derived compounds that affects the immune system. We discuss venoms and venom-derived compounds that affect total immune cell numbers, immune cell proliferation, immune cell migration, immune cell phenotype and cytokine secretion. Identifying novel compounds that 'tune' the system, up-regulating the immune response during infectious disease and cancer and down-regulating the immune response during autoimmunity, will greatly expand the tool kit of human immunotherapeutics. Targeting these pathways may also open therapeutic options that alleviate symptoms of envenomation. Finally, combining recent advances in venomics with progress in low cost, high-throughput screening platforms will no doubt yield hundreds of prototype immune modulating compounds in the coming years.
本综述列举了毒液作为独立治疗剂或药物设计蓝本在知识方面的最新进展,重点关注影响免疫系统的毒液衍生化合物。我们讨论了影响免疫细胞总数、免疫细胞增殖、免疫细胞迁移、免疫细胞表型和细胞因子分泌的毒液及毒液衍生化合物。鉴定能够“调节”该系统的新型化合物,即在传染病和癌症期间上调免疫反应,在自身免疫期间下调免疫反应,将极大地扩充人类免疫治疗的工具库。针对这些途径还可能开辟缓解中毒症状的治疗选择。最后,将毒液组学的最新进展与低成本、高通量筛选平台的进展相结合,未来几年无疑将产生数百种免疫调节化合物原型。